NPHLA Intelligence
Clinical Trial Watch
Trials NPHLA follows, synchronised from ClinicalTrials.gov. We flag what matters (new registrations, changes in status and newly posted results) and ignore routine record edits. Every therapy in a trial is investigational.
- TOPAZ: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
yifang zhu. Conditions: Acute Ischemic Stroke (AIS). Investigational — not approved for the use studied.
- SWIFT: Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer
The Methodist Hospital Research Institute. Conditions: Endometrial Atypical Hyperplasia; Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia; Endometria…. Investigational — not approved for the use studied.
- Evidence-Based Integrated Protocol to Maximize Hair Follicle Survival in Follicular Unit Extraction (FUE)
Assiut University. Conditions: Androgenetic Alopecia; Cicatricial Alopecia. Investigational — not approved for the use studied.
- Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria
Peking University People's Hospital. Conditions: Obesity; Chronic Kidney Disease; Albuminuria. Investigational — not approved for the use studied.
- SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Boehringer Ingelheim. Conditions: Obesity. Investigational — not approved for the use studied.
- ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Boehringer Ingelheim. Conditions: Obesity; Metabolic Dysfunction-associated Steatotic Liver Disease. Investigational — not approved for the use studied.
- TRPTI Metabolic and GLP-1 Pharmacodynamic Study
RDC Clinical Pty Ltd. Conditions: Overweight , Obesity. Investigational — not approved for the use studied.
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
Pfizer. Conditions: Obesity; Overweight and/or Obesity; Overweight; Treatment Of Obesity. Investigational — not approved for the use studied.
- Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Nanjing First Hospital, Nanjing Medical University. Conditions: Obesity / Overweight. Investigational — not approved for the use studied.
- TIRZE-PAP: Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness Trial
Woolcock Institute of Medical Research. Conditions: Sleep Apnoea; Obesity & Overweight; Sleep Apnea Syndrome, Obstructive. Investigational — not approved for the use studied.
- NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study
Istanbul Saglik Bilimleri University. Conditions: Non-arteritic Anterior Ischemic Optic Neuropathy Obesity; Obesity. Investigational — not approved for the use studied.
- A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight
Novo Nordisk A/S. Conditions: Obesity; Overweight. Investigational — not approved for the use studied.
- SEMAFORCRANIO: SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years
University Hospital, Angers. Conditions: Craniopharyngioma, Child. Investigational — not approved for the use studied.
- Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center. Conditions: Endometrial Cancer; Endometrial Intraepithelial Neoplasia; Grade 1 Endometrial Endometrioid Carcinoma. Investigational — not approved for the use studied.
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Eli Lilly and Company. Conditions: Obesity. Investigational — not approved for the use studied.
- ACHIEVE-PEDS: A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Eli Lilly and Company. Conditions: Diabetes Mellitus, Type 2. Investigational — not approved for the use studied.
- Extracorporeal Shockwave Therapy and Platelet-Rich Plasma for Midportion Achilles Tendinopathy
Spaulding Rehabilitation Hospital. Conditions: Achilles Injuries Tendon; Achilles Tendinopathy (AT); Achilles Tendinitis, Left Leg; Achilles Tendinitis, Right Leg; …. Investigational — not approved for the use studied.
- Tirzepatide for the Treatment of Cannabis Use Disorder
Brigham and Women's Hospital. Conditions: Cannabis Use Disorder. Investigational — not approved for the use studied.
- Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome
Banu Erkal. Conditions: Sjogren Syndrome; Xerostomia; Exosome. Investigational — not approved for the use studied.
- Effect of an Intraoperative Polynucleotide Injection on Scar Quality After Thyroidectomy
Dr. Lutfi Kirdar Kartal Training and Research Hospital. Conditions: Postoperative Surgical Scar; Scar; Scar Formation; Neck Scar. Investigational — not approved for the use studied.
- BioM: Biological Profiles of Neuropeptides, Neurotrophins and miRNA in Migraine
Nordlandssykehuset HF. Conditions: Migraine. Investigational — not approved for the use studied.
- AWAKEN: Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Pelage Pharmaceuticals, Inc.. Conditions: Androgenetic Alopecia. Investigational — not approved for the use studied.
- TrichoscopyDM2: Hair Changes in Females With Type 2 Diabetes Clinical and Trichoscopic Examination
Al-Azhar University. Conditions: Diabete Mellitus; Female Androgenetic Alopecia; Dermoscopy. Investigational — not approved for the use studied.
- Botox in HS: Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa
University of Massachusetts, Worcester. Conditions: Hidradenitis Suppurativa (HS). Investigational — not approved for the use studied.
- MONA: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
Apsen Farmaceutica S.A.. Conditions: Alopecia, Androgenetic. Investigational — not approved for the use studied.
- Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia
Activ'inside. Conditions: Androgenic Alopecia; Healthy Adult Male. Investigational — not approved for the use studied.
- PATHS-T2D: PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses
Massachusetts General Hospital. Conditions: Diabete Type 2; Pharmacogenomic Drug Interaction. Investigational — not approved for the use studied.
- Study to Assess Participant Satisfaction After Jawline and Neck Treatment
AbbVie. Conditions: Jawline and Neck Appearance. Investigational — not approved for the use studied.
- ATTAIN-CN: A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health Problems
Eli Lilly and Company. Conditions: Obesity; Overweight. Investigational — not approved for the use studied.
- GLIDE-HF: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
Miedziowe Centrum Zdrowia SA. Conditions: Heart Failure With Preserved Ejection Fraction; Obesity; Diastolic Heart Failure; Pulmonary Hypertension; Iron Defici…. Investigational — not approved for the use studied.
- Impact of Dysport on PMFF Donor Scar
Vanderbilt University Medical Center. Conditions: Skin Cancer Excision Site; Basal Cell Carcinoma; Squamous Cell Carcinoma; Melanoma. Investigational — not approved for the use studied.
- Study of DWP450 in Japanese Subjects With Glabellar Lines
Daewoong Pharmaceutical Co. LTD.. Conditions: Glabellar Lines. Investigational — not approved for the use studied.
- Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy Discontinuation
Massachusetts General Hospital. Conditions: Obesity. Investigational — not approved for the use studied.
- Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis
Peking University. Conditions: Facial Aging; Melomental Folds; Oral Commissure Ptosis. Investigational — not approved for the use studied.
- GLICH: GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Chinese University of Hong Kong. Conditions: Intracerebral Hemorrhage. Investigational — not approved for the use studied.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Trial listings are not recommendations to enrol or prescribe.